487 Results

People

  1. De Angelis
    De Angelis
  2. Abrey
    Abrey
  3. Kelsen
    Kelsen
  4. Lichtman
    Lichtman
  5. Bajorin
    Bajorin
  6. Perales
    Perales
  7. Yahalom
    Yahalom
  8. Saltz
    Saltz
  9. Seidman
    Seidman
  10. Correa
    Correa

Groups

  1. Department of Medicine (257)
  2. Solid Tumor Oncology Division (171)
  3. Hematologic Malignancies, Division of (102)
  4. Center for Hematologic Malignancies (89)
  5. Survivorship Research (72)
  6. Tow Center for Developmental Oncology (TCDO) (51)
  7. Gastrointestinal Oncology Service (50)
  8. Surgery (45)
  9. Genitourinary Oncology Service (42)
  10. Bone Marrow Transplant (38)
  1. "neurotoxicity"
Formats
  1. Journal Article (426)
  2. Review (34)
  3. Editorial (6)
  4. Conference Paper (5)
  5. Book Section (4)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Meeting Abstract (2)
  9. Research Letter (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (257)
  2. Solid Tumor Oncology Division (171)
  3. Hematologic Malignancies, Division of (102)
  4. Center for Hematologic Malignancies (89)
  5. Survivorship Research (72)
  6. Tow Center for Developmental Oncology (TCDO) (51)

More Groups

People
  1. Lisa De Angelis (44)
  2. Lauren Abrey (29)
  3. David Kelsen (19)
  4. Stuart Lichtman (18)
  5. Dean Bajorin (17)
  6. Joachim Yahalom (17)

More People

Years
  1. 2025 (25)
  2. 2024 (26)
  3. 2023 (18)
  4. 2022 (10)
  5. 2021 (5)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (46)
  2. Cancer (19)
  3. Seminars in Oncology (15)
  4. Gynecologic Oncology (13)
  5. Journal of Neuro-Oncology (13)
  6. Blood (11)

More Publications

Publishers
  1. Elsevier Inc. (80)
  2. American Society of Clinical Oncology (47)
  3. Springer (41)
  4. Nature Publishing Group (28)
  5. Wiley Blackwell (27)
  6. Lippincott Williams & Wilkins (26)

More Publishers

Results (487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): A single-arm, open-label, phase 1, dose-escalation study
    Journal Article

    Iyer, S. P.; Sica, R. A.; Ho, P. J.; Prica, A.; Zain, J.; Foss, F. M.; Hu, B.; Beitinjaneh, A.; Weng, W. K.; Kim, Y. H.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • New treatments for adult T-cell leukemia/lymphoma
    Review

    Epstein-Peterson, Z. D.; Gurumurthi, A.; Horwitz, S. M.
    Leukemia Research (2025)

    Fulltext@MSK | Save
  • Effectiveness and safety of combined treatment with herbal medicines and palliative chemotherapy for advanced gastric cancer: A systematic review, and meta-analysis
    Review

    Kim, D. H.; Kim, S. D.; Jun, H. J.; Kwag, E. B.; Shin, S. W.; Yoo, H. S.; Park, S. J.
    Integrative Medicine Research (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • The contemporary spectrum of radiotherapy for hematologic malignancies involving the central nervous system: From focal therapy to craniospinal
    Review

    Cederquist, G. Y.; Tringale, K.; Yahalom, J.; Imber, B. S.
    Seminars in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders
    Editorial

    Usmani, S. Z.; Ghosh, N.; Voorhees, P.; Copelan, E.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of B cell maturation antigen-directed CAR T-cell therapy in patients with relapsed/refractory multiple myeloma and concurrent light chain amyloidosis
    Journal Article

    Goel, U.; Dima, D.; Davis, J.; Ahmed, N.; Shaikh, H.; Lochner, J.; Abdallah, A. O.; Khouri, J.; Hashmi, H.; Anwer, F.
    European Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy
    Review

    Deschè‚nes-Simard, X.; Santomasso, B. D.; Dahi, P. B.
    Blood (2024)

    Fulltext@MSK | Save
  • Proton radiation therapy: A systematic review of treatment-related side effects and toxicities
    Review

    Salem, P. P.; Chami, P.; Daou, R.; Hajj, J.; Lin, H.; Chhabra, A. M.; Simone, C. B. 2nd; Lee, N. Y.; Hajj, C.
    International Journal of Molecular Sciences (2024)

    Fulltext@MSK | Save
  • Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma
    Journal Article

    Benjamini, O.; Fried, S.; Shouval, R.; Flynn, J. R.; Beyar-Katz, O.; Leslie, L. A.; Zuckerman, T.; Yerushalmi, R.; Shem-Tov, N.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save